Press Releases

Active Biotech AB Interim report January - June 2015
August 7, 2015 08:30 (CEST)
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
June 25, 2015 14:27 (CEST)
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
June 25, 2015 14:00 (CEST)
Annual General Meeting of Active Biotech AB
June 12, 2015 08:33 (CEST)
Annual General Meeting of Active Biotech AB
June 12, 2015 08:30 (CEST)
Active Biotech focuses the operations on the laquinimod project and adjusts the organization
June 1, 2015 10:03 (CEST)
Active Biotech focuses the operations on the laquinimod project and adjusts the organization
June 1, 2015 10:00 (CEST)
Notice of Annual General Meeting of Shareholders
May 12, 2015 08:40 (CEST)
Notice of Annual General Meeting of Shareholders
May 12, 2015 08:30 (CEST)
Annual Report 2014 Active Biotech AB (publ)
April 30, 2015 10:04 (CEST)